The reliability off lymphoma diagnosis in small tissue samples is heavily influenced by lymphoma subtype

American Journal of Clinical Pathology

Volumn 128, Issue 3, 2007, Pages 474-480

  Farmer, Patricia L ^a   Bailey, Denis J ^b   Burns, Bruce F ^c   Day, Andrew ^d   LeBrun, David P ^a,e  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d KINGSTON GENERAL HOSPITAL   (Canada)

^e QUEEN S UNIVERSITY   (Canada)

Author keywords

Immunophenotyping; Lymphoma; Needle biopsy; Tissue microarray

Indexed keywords

CD15 ANTIGEN; CD20 ANTIBODY; CD23 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD79A ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; CYCLIN D1; PROTEIN BCL 2; PROTEIN BCL 6;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FOLLICULAR LYMPHOMA; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOCYTE; LYMPHOMA; NEEDLE BIOPSY; PRIORITY JOURNAL; T LYMPHOBLAST; TISSUE MICROARRAY; EVALUATION; METHODOLOGY; OBSERVER VARIATION; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

HUMANS; IMMUNOPHENOTYPING; LYMPHOMA; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS;

EID: 34748849630     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/J7Y74D9DXEAJ9YUY     Document Type: Article

References (15)

1. Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001. World Health Organization Classification of Tumours.
2. Pappa VI, Hussain HK, Reznek RH, et al. Role of image-guided core-needle biopsy in the management of patients with lymphoma. J Clin Oncol. 1996;14:2427-2430.
3. Quinn SF, Sheley RC, Nelson HA, et al. The role of percutaneous needle biopsies in the original diagnosis of lymphoma: a prospective evaluation. J Vasc Interv Radiol. 1995;6:947-952.
4. Screaton NJ, Berman LH, Grant JW. Head and neck lymphadenopathy: evaluation with US-guided cutting-needle biopsy. Radiology. 2002;224:75-81.
5. Demharter J, Muller P, Wagner T, et al. Percutaneous core-needle biopsy of enlarged lymph nodes in the diagnosis and subclassification of malignant lymphomas. Eur Radiol. 2001;11:276-283.
6. Zinzani PL, Cornell G, Cancellieri A, et al. Core needle biopsy is effective in the initial diagnosis of mediastinal lymphoma. Haematologica. 1999;84:600-603.
7. Sklair-Levy M, Amir G, Spectre G, et al. Image-guided cutting-edge-needle biopsy of peripheral lymph nodes and superficial masses for the diagnosis of lymphoma. J Comput Assist Tomogr. 2005;29:369-372.
8. de Kerviler E, Guermazi A, Zagdanski AM, et al. Image-guided core-needle biopsy in patients with suspected or recurrent lymphomas. Cancer. 2000;89:647-652.
9. Balestreri L, Morassut S, Bernardi D, et al. Efficacy of CT-guided percutaneous needle biopsy in the diagnosis of malignant lymphoma at first presentation. Clin Imaging. 2005;29:123-127.
10. Agid R, Sklair-Levy M, Bloom AI, et al. CT-guided biopsy with cutting-edge needle for the diagnosis of malignant lymphoma: experience of 267 biopsies. Clin Radiol. 2003;58:143-147.
11. Sklair-Levy M, Polliack A, Shaham D, et al. CT-guided core-needle biopsy in the diagnosis of mediastinal lymphoma. Eur Radiol. 2000;10:714-718.
12. Parker RL, Huntsman DG, Lesack DW, et al. Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray. Am J Clin Pathol. 2002;117:723-728.
13. Fleiss JL. Statistical Methods for Rates and Proportions. New York, NY: John Wiley; 1981.
14. Hesselmann V, Zahringer M, Krug B, et al. Computed-tomography-guided percutaneous core needle biopsies of suspected malignant lymphomas: impact of biopsy, lesion, and patient parameters on diagnostic yield. Acta Radiol. 2004;45:641-645.
15. Gascoyne RD. Hematopathology approaches to diagnosis and prognosis of indolent B-cell lymphomas. Hematology (Am Soc Hematol Educ Program). 2005:299-306.